HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Chunmeng Shi Selected Research

Sulfobromophthalein (Sulfobromophthalein Sodium)

9/2010A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging.
5/2010Near IR heptamethine cyanine dye-mediated cancer imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Chunmeng Shi Research Topics

Disease

14Neoplasms (Cancer)
01/2015 - 01/2008
7Wounds and Injuries (Trauma)
01/2015 - 01/2003
3Neoplasm Metastasis (Metastasis)
01/2015 - 05/2010
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2010 - 11/2010
2Prostatic Neoplasms (Prostate Cancer)
08/2009 - 08/2008
1Sepsis (Septicemia)
01/2015
1Lymphatic Metastasis
01/2015
1Fibrosis (Cirrhosis)
01/2015
1Lung Neoplasms (Lung Cancer)
04/2014
1Lewis Lung Carcinoma
04/2014
1Pathologic Processes
12/2012
1Mouth Neoplasms (Oral Cancer)
12/2010
1Sarcoma (Soft Tissue Sarcoma)
12/2010

Drug/Important Bio-Agent (IBA)

42- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA
04/2014 - 09/2010
4PeptidesIBA
01/2014 - 05/2010
3LigandsIBA
04/2014 - 10/2011
3Fluorescent Dyes (Fluorescent Probes)IBA
09/2010 - 01/2008
2MicroRNAs (MicroRNA)IBA
01/2015 - 12/2012
2Contrast MediaIBA
04/2014 - 03/2013
2CollagenIBA
12/2012 - 01/2003
2AntibodiesIBA
10/2011 - 01/2009
2Coloring Agents (Dyes)IBA
10/2011 - 05/2010
2Sulfobromophthalein (Sulfobromophthalein Sodium)IBA
09/2010 - 05/2010
2cyanine dye (betacyanin)IBA
09/2010 - 05/2010
2Proliferating Cell Nuclear Antigen (PCNA)IBA
06/2004 - 10/2003
2AntigensIBA
06/2004 - 10/2003
1Small Interfering RNA (siRNA)IBA
01/2015
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
01/2015
1Vascular Endothelial Growth Factor DIBA
01/2015
1Vascular Endothelial Growth Factor CIBA
01/2015
1Adenocarcinoma of lungIBA
01/2015
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2014
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2014
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2013
1Molecular Probes (Molecular Probe)IBA
10/2011
1Proteins (Proteins, Gene)IBA
10/2011
1Cantharidin (Cantharides)IBA
12/2010
1DNA (Deoxyribonucleic Acid)IBA
12/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2010
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
12/2010
1Cell-Penetrating PeptidesIBA
12/2010
1A-factor (Streptomyces)IBA
11/2010
1human glutamate carboxypeptidase IIIBA
08/2009
1Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
08/2008
1Biological Markers (Surrogate Marker)IBA
01/2008
1Carbon MonoxideIBA
11/2004
1PlasticsIBA
01/2003
1Polyvinyl AlcoholIBA
01/2003
1chlorfenethol (DMC)IBA
01/2003
1Hydroxyproline (4 Hydroxyproline)IBA
01/2003

Therapy/Procedure

7Heterologous Transplantation (Xenotransplantation)
01/2015 - 08/2009
4Quantum Dots (Quantum Dot)
12/2010 - 01/2008
3Transplantation (Transplant Recipients)
01/2015 - 01/2003
3Therapeutics
04/2014 - 10/2011
1Ligation
01/2015
1Photochemotherapy (Photodynamic Therapy)
03/2012
1Intravenous Injections
08/2009
1Cell Transplantation
07/2004